In order to assess the lethality of Clostridium difficile-associated disease (CDAD) and the PCR ribotypes prevalent in Austria, the Austrian Agency for Health and Food Safety requested isolates of C. difficile from patients in a structured but arbitrary sampling scheme. In the allocated period from February 2006 to January 2007, local hospital laboratories within each of the nine provinces were asked to submit C. difficile isolates from at least ten cases of CDAD. Confirmation of species identification, toxin detection, susceptibility testing against four antimicrobial agents and typing using a PCR ribotyping method were performed at the reference laboratory. In total, 149 isolates of putative C. difficile were submitted, from which 142 were included for study. Antimicrobial susceptibility patterns revealed resistance to clindamycin in 57 % and high-level resistance to moxifloxacin in 38 % of isolates tested. CDAD manifested as diarrhoea (including eight cases of bloody diarrhoea) in 126 cases (88.7 %), as pseudomembranous colitis in 15 cases (10.6 %) and as toxic megacolon in one case. Twelve of the 142 patients died within 30 days of specimen collection (8.45 % lethality). A lethal outcome occurred in 2/15 cases (13.3 %) when pseudomembranous colitis was present and in 10/126 cases (7.9 %) in the absence of pseudomembranous colitis or toxic megacolon. Among the 142 isolates from 25 health-care facilities, 41 PCR ribotype patterns were found. The most frequent ribotypes were AI-5 (including six lethal cases out of 26 patients), 014 (two out of 24) and 053 (one out of 24). The typing patterns demonstrated the occurrence of clusters in hospitals.
ArroyoL. G.,
KruthS. A.,
WilleyB. M.,
StaempfliH. R.,
LowD. E.,
WeeseJ. S.2005; PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. J Med Microbiol 54:163–166[CrossRef]
AslamS.,
HamillR. J.,
MusherD. M.2005; Treatment of Clostridium difficile -associated disease: old therapies and new strategies. Lancet Infect Dis 5:549–557[CrossRef]
KatoH.,
KatoN.,
KatowS.,
MaegawaT.,
NakamuraS.,
LyerlyD. M.1999; Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains. FEMS Microbiol Lett 175:197–203[CrossRef]
KuijperE. J.,
CoignardB.,
TullP.2006; Emergence of Clostridium difficile -associated disease in North America and Europe. Clin Microbiol Infect 12 (Suppl. 6):2–18
KuijperE. J.,
CoignardB.,
BrazierJ.,
SuetensC.,
DrudyD.,
WiuffC.,
PituchH.,
ReichertP.,
SchneiderF.other authors2007; Update of Clostridium difficile -associated disease due to PCR ribotype 027 in Europe. Euro Surveill 12:163–166
PituchH.,
BrazierJ. S.,
Obuch-WoszczatyńskiP.,
WultańskaD.,
Meisel-MikołajczykF.,
ŁuczakM.2006; Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance. J Med Microbiol 55:207–213[CrossRef]
SpigagliaP.,
MastrantonioP.2002; Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40:3470–3475[CrossRef]
SpigagliaP.,
MastrantonioP.2004; Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J Med Microbiol 53:1129–1136[CrossRef]
StubbsS.,
RupnikM.,
GibertM.,
BrazierJ.,
DuerdenB.,
PopoffM.2000; Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile
. FEMS Microbiol Lett 186:307–312[CrossRef]
TerhesG.,
UrbanE.,
SokiJ.,
HamidK. A.,
NagyE.2004; Community-acquired Clostridium difficile diarrhea caused by binary toxin, toxin A, and toxin B gene-positive isolates in Hungary. J Clin Microbiol 42:4316–4318[CrossRef]
TerhesG.,
BrazierJ. S.,
UrbanE.,
SokiJ.,
NagyE.2006; Distribution of Clostridium difficile PCR ribotypes in regions of Hungary. J Med Microbiol 55:279–282[CrossRef]
van den BergR. J.,
ClaasE. C. J.,
OyibD. H.,
KlaassenC. H. W.,
DijkshoornL.,
BrazierJ. S.,
KuijperE. J.2004; Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol 42:1035–1041[CrossRef]
van den BergR. J.,
AmeenH. A.,
FurusawaT.,
ClaasE. C.,
van der VormE. R.,
KuijperE. J.2005; Coexistence of multiple PCR-ribotype strains of Clostridium difficile in faecal samples limits epidemiological studies. J Med Microbiol 54:173–179[CrossRef]
ViscidiR.,
WilleyS.,
BartlettJ. G.1981; Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 81:5–9